Life sciences briefing: Monday, Dec. 3, 2007

Life sciences briefing: Monday, Dec. 3, 2007

Featured companies: CoMentis, ForHealth Technologies, Merrimack Pharmaceuticals, QuantomiX, Progenitor Cell Therapy, River Diagnostics, Topaz Pharmaceuticals

UPDATED: Expanded items on CoMentis, Topaz and ForHealth.

CoMentis gets $12M for eye, Alzheimer’s treatments — South San Francisco’s CoMentis, a biotech pursuing treatments for Alzheimer’s disease and macular degeneration, raised $12 million in a third funding round, VentureWire reports (subscription required). Wellington Management provided the funding.

The company’s lead drug candidate, ATG003, is an eye drop designed to treat age-related macular degeneration (AMD), a… Continue Reading

Life sciences briefing: Friday, Sept. 21, 2007

Life sciences briefing: Friday, Sept. 21, 2007

Featured companies: CG Therapeutics, Complete Genomics, ConforMIS, Flexible Medical Systems, LeMaitre Vascular, MAP Pharmaceuticals, ParaPro, Vascular Architects, Zars Pharma

(UPDATED on 10/1/07: See below.)

[NOTE: Posting has been slow recently for personal reasons. I'll be doing my best to catch up today.]

Complete Genomics raises funding for high-speed sequencing — Complete Genomics, a Mountain View, Calif., developer of high-speed genome sequencing technology, said it raised an undisclosed sum in a second funding round, VentureWire reports (subscription required). The company said… Continue Reading